The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view

Recent advances in clinical medicine have elucidated two significantly different subtypes of glioblastoma which carry very different prognoses, both defined by mutations in isocitrate dehydrogenase-1 (IDH-1). The mechanistic consequences of this mutation have not yet been fully clarified, with conflicting opinions existing in the literature; however, IDH-1 mutation may be used as a surrogate marker to distinguish between primary and secondary glioblastoma multiforme (sGBM) from malignant progression of a lower grade glioma. We develop a mathematical model of IDH-1 mutated secondary glioblastoma using evolutionary game theory to investigate the interactions between four different phenotypic populations within the tumor: autonomous growth, invasive, glycolytic, and the hybrid invasive/glycolytic cells. Our model recapitulates glioblastoma behavior well and is able to reproduce two recent experimental findings, as well as make novel predictions concerning the rate of invasive growth as a function of vascularity, and fluctuations in the proportions of phenotypic populations that a glioblastoma will experience under different microenvironmental constraints.

[1]  Christos Davatzikos,et al.  An image-driven parameter estimation problem for a reaction–diffusion glioma growth model with mass effects , 2008, Journal of mathematical biology.

[2]  K. Mathieson,et al.  The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood , 2009, Journal of Neuro-Oncology.

[3]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[4]  Y. Matsukado,et al.  The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. , 1961, Journal of neurosurgery.

[5]  Albert Lai,et al.  Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. , 2009, Cancer research.

[6]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[7]  L. Deangelis,et al.  Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma , 2009, Neurology.

[8]  E. T. Gawlinski,et al.  The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. , 2003, Cancer research.

[9]  M. Aghili,et al.  Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review , 2008, Journal of Neuro-Oncology.

[10]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[11]  A. Deutsch,et al.  Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion , 2008, Cell proliferation.

[12]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[13]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[14]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[16]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[17]  Kristin R. Swanson,et al.  The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.

[18]  J. Murray,et al.  A quantitative model for differential motility of gliomas in grey and white matter , 2000, Cell proliferation.

[19]  P. Maini,et al.  Mathematical oncology: Cancer summed up , 2003, Nature.

[20]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[21]  Susan M. Chang,et al.  A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. , 2010, Neuro-oncology.

[22]  Jörgen W. Weibull,et al.  Evolutionary Game Theory , 1996 .

[23]  S. Coons,et al.  Dichotomy of astrocytoma migration and proliferation , 1996, International journal of cancer.

[24]  M. Nowak,et al.  Evolutionary game theory , 1995, Current Biology.

[25]  P. Kleihues,et al.  IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.

[26]  A. Unterberg,et al.  Different angiogenic phenotypes in primary and secondary glioblastomas , 2006, International journal of cancer.

[27]  A. Gregory Sorensen,et al.  Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.

[28]  E. T. Gawlinski,et al.  Acid-mediated tumor invasion: a multidisciplinary study. , 2006, Cancer research.